Literature DB >> 9278212

Erythropoietin production in healthy volunteers subjected to controlled hypobaric hypoxia: further evidence against a role for adenosine.

C H Gleiter1, T Becker, J Wenzel.   

Abstract

AIMS: Objective of this study was to investigate whether adenosine modulates renal erythropoietin production.
METHODS: In the present study erythropoietin production was stimulated by hypobaric hypoxia by subjecting healthy volunteers to a simulated altitude of 4000 m in a low pressure chamber for 5.5 h. During exposure to hypoxia the subjects received i.v. in a randomized, single-blind, cross-over fashion the non-specific adenosine antagonist theophylline, the adenosine reuptake inhibitor dipyridamole and placebo.
RESULTS: Contrary to the working hypothesis, theophylline did not decrease and dipyridamole did not further boost erythropoietin concentrations.
CONCLUSIONS: The results are in agreement with our earlier study using haemorrhage as a controlled physiological stimulus of erythropoietin production, and would question a major role for adenosine as a mediator of renal erythropoietin production.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9278212      PMCID: PMC2042831          DOI: 10.1046/j.1365-2125.1997.00638.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  3 in total

1.  Fenoterol stimulates human erythropoietin production via activation of the renin angiotensin system.

Authors:  S M Freudenthaler; T Schenck; I Lucht; C H Gleiter
Journal:  Br J Clin Pharmacol       Date:  1999-10       Impact factor: 4.335

2.  Do alterations of endogenous angiotensin II levels regulate erythropoietin production in humans?

Authors:  S Freudenthaler; P Benöhr; A Grenz; T Selzer; T Schmidt; K Mörike; H Osswald; C H Gleiter
Journal:  Br J Clin Pharmacol       Date:  2003-10       Impact factor: 4.335

3.  Adenosine produced via the CD73/ecto-5'-nucleotidase pathway has no impact on erythropoietin production but is associated with reduced kidney weight.

Authors:  Burcin Ozüyaman; Zhaoping Ding; Anja Buchheiser; Patrycja Koszalka; Norbert Braun; Axel Gödecke; Ulrich K M Decking; Herbert Zimmermann; Jürgen Schrader
Journal:  Pflugers Arch       Date:  2006-02-09       Impact factor: 3.657

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.